#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunoglobulin G4 related disease Antithrombin III deficiency Dermatitis Ischaemic stroke Keratosis follicular Systemic lupus erythematosus Idiopathic pulmonary fibrosis Pleural mesothelioma Pancreatic carcinoma metastatic Plasma cell myeloma recurrent Antiphospholipid antibodies Alport's syndrome Ataxia telangiectasia Arrhythmogenic right ventricular dysplasia Sickle cell disease More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy Mucopolysaccharidosis I – Diagnostics Myelodysplastic syndrome – Treatment Lysosomal storage disorder – Treatment Atypical haemolytic uraemic syndrome – Life with Disease Soft tissue sarcoma – Diagnostics Pulmonary fibrosis – Diagnostics Synovial sarcoma – Trials in Disease Alternating hemiplegia of childhood – Trials in Disease Sjogren’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ilofotase Alfa LIPASE Redasemtide Peginterferon Alfa-2A Cefepime Hydrochloride Dutasteride Flortaucipir (18F) Efinopegdutide Lutetium (177Lu)-Neobomb1 Risankizumab AZD5148 Relatlimab Masofaniten Ucart20X22 Letetresgene Autoleucel Naproxen Sodium Tyrosine ABY-271 ULEFNERSEN Clascoterone More therapies…

    Learn about Your Condition

    Thalassaemia Pleural mesothelioma malignant Breast angiosarcoma Death neonatal Lung adenocarcinoma stage IV Heparin resistance Bone marrow failure Haemorrhoids Infant sedation Testicular leiomyosarcoma Primary hyperthyroidism Bladder cancer recurrent Laryngeal cancer Anal cancer stage II Stem cell transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinic “ELPIS”

Clinic “ELPIS”

118, Anthimou Gazi str., Volos, 38221, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Masitinib
    France Greece Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!